Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

TGA Issues Guidance on Clinical Decision Support Software

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

Beginning Feb. 25, the way that software-based medical devices are regulated in Australia will change, and clinical decision support software (CDSS) that meets the definition of a medical device must…

Continue ReadingTGA Issues Guidance on Clinical Decision Support Software

New MDR Notified Body Designated in Finland

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

SGS FIMKO Oy, a Helsinki-based subsidiary of the certification giant SGS, became the 18th notified body to be designated to provide product certifications under the European Medical Device Regulation (MDR).…

Continue ReadingNew MDR Notified Body Designated in Finland

EC Details How Legacy Devices Will Be Managed in Eudamed

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The European Commission released new guidance explaining how Legacy Devices will be identified in the Eudamed database and how their unique device identifiers will be generated and assigned. Source: The…

Continue ReadingEC Details How Legacy Devices Will Be Managed in Eudamed

FDA’s Device Center Has COVID Test Regrets

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The FDA’s top device officials admit that allowing a flood of COVID-19 diagnostic tests onto the market last year that did not go through the usual clearance or approval steps…

Continue ReadingFDA’s Device Center Has COVID Test Regrets

FDA Appoints Kevin Fu As First Medical Device Cybersecurity Chief

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The FDA has named Kevin Fu as acting director of medical device cybersecurity within the Center for Devices and Radiological Health (CDRH) — a newly created position in response to…

Continue ReadingFDA Appoints Kevin Fu As First Medical Device Cybersecurity Chief

New Postmarket Surveillance Tool for COVID-19 Vaccines

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

Health officials are using new tools to gather postmarket safety data on COVID-19 vaccines, including a new early warning system called V-Safe. Source: The GMP Letter

Continue ReadingNew Postmarket Surveillance Tool for COVID-19 Vaccines

EC Agrees on Common List of COVID-19 Rapid Antigen Tests

  • Post author:Sam
  • Post published:March 4, 2021
  • Post category:The GMP Letter

The European Commission (EC) has agreed on a common framework for the use and validation of rapid antigen tests and COVID-19 test results that EU member states will mutually recognize,…

Continue ReadingEC Agrees on Common List of COVID-19 Rapid Antigen Tests

New Postmarket Surveillance Tool for COVID-19 Vaccines Being Used

  • Post author:Sam
  • Post published:March 1, 2021
  • Post category:Drug GMP Report

As U.S. vaccinations against COVID-19 gain momentum, health officials are using new tools to gather postmarket safety data, including a new early warning system called V-Safe. Source: Drug GMP Report

Continue ReadingNew Postmarket Surveillance Tool for COVID-19 Vaccines Being Used

FDA Preparing Guidance on Compounding Pandemic Drugs

  • Post author:Sam
  • Post published:March 1, 2021
  • Post category:Drug GMP Report

The FDA announced that it is developing guidance on compounding drugs during the COVID-19 pandemic to protect patients from “unsafe, ineffective and poor-quality compounded drugs, while preserving access for patients.”…

Continue ReadingFDA Preparing Guidance on Compounding Pandemic Drugs

FDA Drug Recalls Rise in 2020, New Report Says

  • Post author:Sam
  • Post published:March 1, 2021
  • Post category:Drug GMP Report

Drug recalls in 2020 climbed to 344, a 2.4 percent increase from the previous year, although that small increase was overshadowed by the amount of drugs actually impacted by the…

Continue ReadingFDA Drug Recalls Rise in 2020, New Report Says
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.